Biohaven pharmaceutical holding company ltd.

Major-Pharmaceuticals

BHVN


215 Church Street
New Haven , CT 06510

Executive/
Director

Price

  • Last Close
  • $ 38.62
    $ +1.41 3.79 %
    Jan 3, 2025
  • 52-Week High/Low
  • $61.3 - $16.92
  • YTD
  • 3.3%

  • Trading Volume
  • 25,507
  • Market Cap Full
  • $ 3.1B
  • Shares Outstanding
  • 80.2M
    Nov 10, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - -4.5% 39.2% -5% -20.3% -14% -1.6% 28.5% 3.3%
Q2 - 42.9% 61.1% -15.3% 4% 42% 22.9% 75.1% -32.7% -
Q3 - 49.5% -8.9% -4% 8% 41.7% -95.7% 8.7% 1.1% -
Q4 - -24.1% -0.7% 30.6% 31.7% 0.2% 120.3% 77.7% -29.5% -
J F M A M J J A S O N D
2025 3.3% - - - - - - - - - - -
2024 3.9% 8% 14.5% -29.1% -10% -0.3% 12.4% 1.1% - - - -18.9%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%37%48%56%61%-90%208%-13%3%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 1.74 -2.32 -1.41 -3.07 -4.27 - -1.03
Q2 - 1.78 -1.01 -4.67 -3.08 -3.23 - -1.32
Q3 - 1.19 -1.53 -2.04 -3.27 -2.63 - -1.50
Q4 - 0.75 -1.29 -2.79 -3.64 -5.43 -1.82 -
A 0 5.5 -6.2 -10.9 -3 -5.4 -12.8 -3.85

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2022 2023
Mar - 68.2
Jun - 68.2
Sep - 68.3
Dec 68.2 80.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - 1.1 0.5 - -
Fixed Asset Turnover - 3.2 1.5 - -
Total Asset Turnover - 0.4 0.1 - -
Leverage
Debt Ratio - 0.7 0.4 - -
Debt – Equity Ratio - -0.8 -0.7 - -
Interest Coverage -284 -4.9 -5.3 -9.6 -14.1
Equity multiplier 0.1 -0.2 -0.1 -2.1 0.1